TNI medical AG, a Würzburg, Germany-based medical device company, raised €3m in venture capital funding.
Pathena Fund made the investment.
Led by CEO Ewald Anger, TNI medical develops, produces, and sells devices for respiratory therapy, for both clinical intensive and inpatient care as well as for home care use. The recently introduced TNI®softFlow systems allows the maximiation of patient comfort with provision of full respiratory support.
The diseases primarily treated in adults with the company’s devices are COPD and ILD as well as prematures and newborns suffering from IRDS, BPD, Bronchiolitis and mild to moderate obstructive sleep apnea syndrome.